Literature DB >> 18663816

Gene expression profiling of breast cancer to select women for adjuvant chemotherapy.

.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18663816

Source DB:  PubMed          Journal:  Technol Eval Cent Assess Program Exec Summ


× No keyword cloud information.
  4 in total

1.  Debating clinical utility.

Authors:  Wylie Burke; A-M Laberge; N Press
Journal:  Public Health Genomics       Date:  2010-04-15       Impact factor: 2.000

2.  Tumor gene expression profiling in women with breast cancer. Test category: prognostic.

Authors:  Cecelia Bellcross; W David Dotson
Journal:  PLoS Curr       Date:  2010-09-02

3.  Use of Oncotype DX in Women with Node-Positive Breast Cancer.

Authors:  Naoko Ishibe; Sheri Schully; Andrew Freedman; Scott David Ramsey
Journal:  PLoS Curr       Date:  2011-07-21

4.  Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies.

Authors:  Patricia A Deverka; Sheri D Schully; Naoko Ishibe; Josh J Carlson; Andrew Freedman; Katrina A B Goddard; Muin J Khoury; Scott D Ramsey
Journal:  Genet Med       Date:  2012-07       Impact factor: 8.822
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.